NOL12 and hepatocellular carcinoma: In conclusion, our findings revealed the expression pattern and prognostic and tumorigenic roles of NOL12 and identified NOL12 as a novel oncogene and potential therapeutic target in HCC that may be achieved by affecting the TME.